Abstract
Despite advances in robotic-assisted surgery (RAS) in the past two decades, control of the robotic system currently remains under the command of a human surgeon. Historically, urology has pioneered new surgical techniques and technologies. Now, autonomous RAS is on the horizon and the first data from clinical trials of autonomous RAS in urology are being published. Automation takes control away from the surgeon but promises standardization of techniques, increased efficiency, potentially reduced complication rates and new ways of integrating intra-operative imaging. Preclinical and clinical evidence is emerging that supports the use of autonomous robotic-assisted urological surgery. Use of autonomous technologies in the operating theatre will directly affect the role of the urological surgeon. Integration of autonomous RAS can be viewed as a positive aid, but it might also be perceived as a threat to the future urological surgeon.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Khadhouri, S. et al. The British Association of Urological Surgeons (BAUS) radical prostatectomy audit 2014/2015 — an update on current practice and outcomes by centre and surgeon case-volume. BJU Int. 121, 886–892 (2018).
Rassweiler, J. J. et al. Future of robotic surgery in urology. BJU Int. 120, 822–841 (2017).
Gilling, P., Reuther, R., Kahokehr, A. & Fraundorfer, M. Aquablation–image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 117, 923–929 (2016).
Gilling, P. et al. WATER: a double-blind, randomized, controlled trial of aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia. J. Urol. 199, 1252–1261 (2018).
International Organization for Standardization. ISO 8373:2012 Robots and robotic devices — vocabulary. ISO https://www.iso.org/standard/55890.html (2012).
Yang, G. et al. Medical robotics — regulatory, ethical, and legal considerations for increasing levels of autonomy. Sci. Robot. 2, 8638 (2017).
Shademan, A. et al. Supervised autonomous robotic soft tissue surgery. Sci. Transl Med. 8, 337ra64 (2016).
Santoni de Sio, F. & Van den Hoven, J. Meaningful human control over autonomous systems: a philosophical account. Front. Robot. AI 5, 15 (2018).
Harris, S. J. et al. The Probot — an active robot for prostate resection. Proc. Inst. Mech. Eng. H. 211, 317–325 (1997).
Cornu, J. et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur. Urol. 67, 1066–1096 (2015).
Faber, K. et al. Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J. Endourol. 29, 63–69 (2015).
Desai, M. et al. WATER II (80–150 mL) procedural outcomes. BJU Int. 123, 106–112 (2019).
Podder, T. K. et al. AAPM and GEC–ESTRO guidelines for image-guided robotic brachytherapy: report of Task Group 192. Med. Phys. 41, 101501 (2014).
Patriciu, A. et al. Automatic brachytherapy seed placement under MRI guidance. IEEE Trans. Biomed. Eng. 54, 1499–1506 (2007).
Muntener, M. et al. Magnetic resonance imaging compatible robotic system for fully automated brachytherapy seed placement. Urology 68, 1313–1317 (2006).
Hempel, E. et al. An MRI-compatible surgical robot for precise radiological interventions. Comput. Aided Surg. 8, 180–191 (2003).
Stoianovici, D. et al. “MRI Stealth” robot for prostate interventions. Minim. Invasive Ther. Allied Technol. 16, 241–248 (2007).
Podder, T. K. et al. Reliability of EUCLIDIAN: an autonomous robotic system for image-guided prostate brachytherapy. Med. Phys. 38, 96–106 (2011).
Popescu, T., Kacsó, A. C., Pisla, D. & Kacsó, A. P. G. Brachytherapy next generation: robotic systems. J. Contemp. Brachytherapy 7, 510–514 (2015).
Shah, T. T. et al. Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry. Eur. Urol. 76, 98–105 (2019).
Catto, J. W. et al. Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study. BMJ Open 8, e020500 (2018).
Oleari, E. et al. Enhancing Surgical Process Modeling for Artificial Intelligence Development in Robotics: the SARAS case study for Minimally Invasive Procedures (2019 13th International Symposium on Medical Information and Communication Technology (ISMICT)) (IEEE, 2019)
Chang, K. D., Abdel Raheem, A., Choi, Y. D., Chung, B. H. & Rha, K. H. Retzius-sparing robot-assisted radical prostatectomy using the Revo-i robotic surgical system: surgical technique and results of the first human trial. BJU Int. 122, 441–448 (2018).
Ferng, A. Meet Versius, Cambridge Medical Robotics’ portable and cost effective robot for minimal access surgery. Medgadget https://www.medgadget.com/2017/11/cambridge-medical-robotics-minimal-access-surgery-versius.html (2017).
Gagnon, L., Goldenberg, S. L., Lynch, K., Hurtado, A. & Gleave, M. E. Comparison of open and robotic-assisted prostatectomy: The University of British Columbia experience. Can. Urol. Assoc. J. 8, 92–97 (2014).
Forsmark, A. et al. Health economic analysis of open and robot-assisted laparoscopic surgery for prostate cancer within the prospective multicentre LAPPRO trial. Eur. Urol. 74, 816–824 (2018).
Lee, N. Robotic surgery: where are we now? Lancet 384, 1417 (2014).
Udwadia, T. E. Robotic surgery is ready for prime time in India: against the motion. J. Minim. Access. Surg. 11, 5–9 (2015).
Manny, T. B., Krane, L. S. & Hemal, A. K. Indocyanine green cannot predict malignancy in partial nephrectomy: histopathologic correlation with fluorescence pattern in 100 patients. J. Endourol. 27, 918–921 (2013).
Cacciamani, G. E. et al. Best practices in near-infrared fluorescence imaging with indocyanine green (NIRF/ICG)-guided robotic urologic surgery: a systematic review-based expert consensus. World J. Urol. 38, 883–896 (2020).
Qian, L., Wu, J. Y., DiMaio, S. P., Navab, N. & Kazanzides, P. A review of augmented reality in robotic-assisted surgery. IEEE Trans. Med. Robot. Bionics 2, 1–16 (2020).
Elmi-Terander, A. et al. Pedicle screw placement using augmented reality surgical navigation with intraoperative 3D imaging: a first in-human prospective cohort study. Spine 44, 517–525 (2019).
Porpiglia, F. et al. Three-dimensional elastic augmented-reality robot-assisted radical prostatectomy using hyperaccuracy three-dimensional reconstruction technology: a step further in the identification of capsular involvement. Eur. Urol. 76, 505–514 (2019).
Chen, J. et al. Use of automated performance metrics to measure surgeon performance during robotic vesicourethral anastomosis and methodical development of a training tutorial. J. Urol. 200, 895–902 (2018).
Landro, L. The Operating Room of the Future. (The Wall Street Journal, 2018).
Alemzadeh, H., Raman, J., Leveson, N., Kalbarczyk, Z. & Iyer, R. K. Adverse events in robotic surgery: a retrospective study of 14 years of FDA data. PLoS ONE 11, e0151470 (2016).
Pierce, H. et al. Patient injuries and malfunctions associated with robotic prostatectomy: review of the manufacturer and user facility device experience database. J. Robot. Surg. https://doi.org/10.1007/s11701-020-01088-1 (2020).
Dyer, C. Senior surgeon’s conviction for manslaughter is quashed. BMJ 355, i6178 (2016).
Gless, S., Silverman, E. & Weigend, T. If robots cause harm, who is to blame? Self-driving cars and criminal liability. N. Crim. Law Rev. 19, 412–436 (2016).
Author information
Authors and Affiliations
Contributions
A.R. and M.J.C. researched data for the article and made substantial contributions to discussion of its content. All authors participated in writing and reviewing and/or editing the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
M.J.C. receives funding from the Wellcome Trust & University College London Hospitals (UCLH) Charity. P.D. receives funding from MRC, Wellcome Trust, NIHR BRC, EPSRC, EUFP7, Vattikuti Foundation, PCRC and TUF. H.U.A. receives funding from Sonacare Medical, Sophiris Inc. and Trod Medical for trials, personal fees for trial/research consultancy from Sophiris Inc, funding for travel, lectures and proctoring fees from Sonacare Inc. and BTG Medical (previously Galil), funding from the Wellcome Trust, and he receives infrastructure support provided by the NIHR Imperial Biomedical Research Centre. A.R. declares no competing interests.
Additional information
Peer review information
Nature Reviews Urology thanks R. Autorino and K. Zorn for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Connor, M.J., Dasgupta, P., Ahmed, H.U. et al. Autonomous surgery in the era of robotic urology: friend or foe of the future surgeon?. Nat Rev Urol 17, 643–649 (2020). https://doi.org/10.1038/s41585-020-0375-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-020-0375-z
This article is cited by
-
Artificial intelligence in the management of prostate cancer
Nature Reviews Urology (2024)
-
A surgical activity model of laparoscopic cholecystectomy for co-operation with collaborative robots
Surgical Endoscopy (2024)
-
Landmarks in the evolution of prostate biopsy
Nature Reviews Urology (2023)